MOLINA HEALTHCARE INC (1MOH.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1MOH - US60855R1005 - Common Stock
154.25 EUR
+11.7 (+8.21%)
We assign a fundamental rating of 5 out of 10 to 1MOH. 1MOH was compared to 32 industry peers in the Health Care Providers & Services industry. 1MOH has an average financial health and profitability rating. 1MOH has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- 1MOH had positive earnings in the past year.
- 1MOH had a negative operating cash flow in the past year.
- In the past 5 years 1MOH has always been profitable.
- Each year in the past 5 years 1MOH had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 5.62%, 1MOH belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
- 1MOH's Return On Equity of 21.07% is amongst the best of the industry. 1MOH outperforms 96.88% of its industry peers.
- 1MOH's Return On Invested Capital of 11.98% is amongst the best of the industry. 1MOH outperforms 84.38% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for 1MOH is significantly above the industry average of 7.02%.
- The 3 year average ROIC (17.96%) for 1MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROIC | 11.98% |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
1.3 Margins
- The Profit Margin of 1MOH (1.98%) is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of 1MOH has declined.
- The Operating Margin of 1MOH (2.97%) is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of 1MOH has declined.
- 1MOH's Gross Margin of 13.91% is in line compared to the rest of the industry. 1MOH outperforms 46.88% of its industry peers.
- In the last couple of years the Gross Margin of 1MOH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% |
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
2. Health
2.1 Basic Checks
- 1MOH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for 1MOH has been reduced compared to 1 year ago.
- Compared to 5 years ago, 1MOH has less shares outstanding
- 1MOH has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.32 indicates that 1MOH is not in any danger for bankruptcy at the moment.
- 1MOH's Altman-Z score of 4.32 is amongst the best of the industry. 1MOH outperforms 87.50% of its industry peers.
- 1MOH has a Debt/Equity ratio of 0.92. This is a neutral value indicating 1MOH is somewhat dependend on debt financing.
- 1MOH's Debt to Equity ratio of 0.92 is in line compared to the rest of the industry. 1MOH outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.32 |
ROIC/WACC1.43
WACC8.39%
2.3 Liquidity
- 1MOH has a Current Ratio of 1.68. This is a normal value and indicates that 1MOH is financially healthy and should not expect problems in meeting its short term obligations.
- 1MOH has a better Current ratio (1.68) than 78.13% of its industry peers.
- 1MOH has a Quick Ratio of 1.68. This is a normal value and indicates that 1MOH is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of 1MOH (1.68) is better than 90.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
- 1MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.06%.
- 1MOH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.16% yearly.
- Looking at the last year, 1MOH shows a quite strong growth in Revenue. The Revenue has grown by 13.65% in the last year.
- 1MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.29% yearly.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
3.2 Future
- Based on estimates for the next years, 1MOH will show a small growth in Earnings Per Share. The EPS will grow by 4.82% on average per year.
- 1MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.46% yearly.
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y4.82%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y5.46%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 9.72, the valuation of 1MOH can be described as very reasonable.
- 93.75% of the companies in the same industry are more expensive than 1MOH, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of 1MOH to the average of the S&P500 Index (27.47), we can say 1MOH is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 13.10, the valuation of 1MOH can be described as correct.
- 1MOH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1MOH is cheaper than 65.63% of the companies in the same industry.
- 1MOH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.26.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.72 | ||
| Fwd PE | 13.1 |
4.2 Price Multiples
- 100.00% of the companies in the same industry are more expensive than 1MOH, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.26 |
4.3 Compensation for Growth
- The decent profitability rating of 1MOH may justify a higher PE ratio.
- 1MOH's earnings are expected to decrease with -10.35% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
5. Dividend
5.1 Amount
- 1MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1MOH (1/7/2026, 7:00:00 PM)
154.25
+11.7 (+8.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners113.09%
Inst Owner ChangeN/A
Ins Owners1.33%
Ins Owner ChangeN/A
Market Cap7.93B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target145.72 (-5.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-8.3%
PT rev (3m)N/A
EPS NQ rev (1m)-64.18%
EPS NQ rev (3m)-90.14%
EPS NY rev (1m)-4.22%
EPS NY rev (3m)-25.12%
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.72 | ||
| Fwd PE | 13.1 | ||
| P/S | 0.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.2 | ||
| P/tB | 4.63 | ||
| EV/EBITDA | 0.26 |
EPS(TTM)15.87
EY10.29%
EPS(NY)11.78
Fwd EY7.63%
FCF(TTM)-9.61
FCFYN/A
OCF(TTM)-7.72
OCFYN/A
SpS745.64
BVpS70.15
TBVpS33.29
PEG (NY)N/A
PEG (5Y)0.69
Graham Number158.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROCE | 16.11% | ||
| ROIC | 11.98% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% | ||
| FCFM | N/A |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 56.78% | ||
| Cap/Sales | 0.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 4.32 |
F-Score4
WACC8.39%
ROIC/WACC1.43
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y4.82%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y5.46%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.25%
EBIT Next 3Y-9.54%
EBIT Next 5YN/A
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%
MOLINA HEALTHCARE INC / 1MOH.MI FAQ
What is the fundamental rating for 1MOH stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1MOH.MI.
What is the valuation status for 1MOH stock?
ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (1MOH.MI). This can be considered as Fairly Valued.
What is the profitability of 1MOH stock?
MOLINA HEALTHCARE INC (1MOH.MI) has a profitability rating of 6 / 10.
What is the valuation of MOLINA HEALTHCARE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (1MOH.MI) is 9.72 and the Price/Book (PB) ratio is 2.2.
What is the earnings growth outlook for MOLINA HEALTHCARE INC?
The Earnings per Share (EPS) of MOLINA HEALTHCARE INC (1MOH.MI) is expected to decline by -36.42% in the next year.